Cellectis
CLLS
#8359
Rank
C$0.40 B
Marketcap
C$4.00
Share price
1.43%
Change (1 day)
46.07%
Change (1 year)

Cellectis (CLLS) - Net assets

Net assets on the balance sheet as of March 2026 : C$84.43 Million

According to Cellectis's latest financial reports the company has C$84.43 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Cellectis - Net assets on balance sheet (from 2008 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$C$0.10 B-44.72%
2024-12-31$C$0.18 B67.38%
2023-12-31$C$0.11 B-34.27%
2022-12-31$C$0.17 B-43.29%
2021-12-31$C$0.30 B-23.47%
2020-12-31$C$0.39 B-15.18%
2019-12-31$C$0.46 B-24.31%
2018-12-31$C$0.61 B71.79%
2017-12-31$C$0.35 B-3.27%
2016-12-31$C$0.36 B-7.68%
2015-12-31$C$0.39 B375.96%
2014-12-31$C$84 M2170.43%
2013-12-31$C$3.69 M-94.74%
2012-12-31$C$70.28 M86.66%
2011-12-31$C$37.65 M-24.42%
2010-12-31$C$49.82 M-26.91%
2009-12-31$C$68.16 M21.36%
2008-12-31$C$56.17 M29.31%
2007-12-31$C$43.43 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Regeneron Pharmaceuticals
REGN
C$44.28 B 52,342.59%๐Ÿ‡บ๐Ÿ‡ธ USA
uniQure
QURE
C$0.21 B 149.24%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
Novavax
NVAX
-C$0.21 Billion-341.59%๐Ÿ‡บ๐Ÿ‡ธ USA